Policy / Pricing FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars Big Molecule WatchThe U.S.Policy / PricingRead full story pharminent April 22, 2026 (Last updated: April 23, 2026) Big Molecule Watch The U.S. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Medicare weight loss drug pilot on ice as insurers decline to contributeNext: AbbVie makes record investment in North Carolina plant Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
